NCT05630300View on ClinicalTrials.gov

Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

NACompletedINTERVENTIONAL
Enrollment

1,280

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

August 30, 2023

Study Completion Date

September 30, 2023

Conditions
COVID-19 Pandemic
Interventions
DIAGNOSTIC_TEST

PMC Sure Status COVID-19 Antigen Test

COVID-19 professional use kit in out-patient departments

DIAGNOSTIC_TEST

Acon Flowflex COVID-19 Antigen Home Test

COVID-19 self-test kits

Trial Locations (4)

7404

Kisenyi Health Center IV, Kampala

Kiswa Health Center III, Kampala

Katikamu Health Center III, Luwero

Luwero Hospital, Luwero

All Listed Sponsors
lead

PATH

OTHER

NCT05630300 - Feasibility and Usability of COVID-19 Antigen RDTs in Uganda | Biotech Hunter | Biotech Hunter